Multiple Sclerosis Study

 

  • We currently have a study for MS where if eligible, you will receive either the study medication or an already approved medication for MS. This study is comparing a new medication to a medication already on the market, Tecfidera. In this study, patients will receive either a regiment of investigational medication or Tecfidera for about six weeks. After that, there is a choice to enter a long term open label study where you would receive the investigational medication. Click the buttons below for more information on the initial study and the open label study. Initial Study  /  Open Label

At NEICR all of our clinical trials (and procedures associated with them) come at no cost to you. If you are interested in participating or have any questions, feel free to fill out the form below or give us a call at (203) 914-1903 for more information.

 

Use the form below to enroll

Multiple Sclerosis - Clinical Study Enrollment
First
Last
Sending